Pfizer 2026년 4월 28일 Pfizer’s victory in delaying Vyndamax generics is mixed bag for BridgeBio: analysts - Fierce Pharma
Pfizer 2026년 4월 28일 BofA raises BridgeBio Pharma stock price target on Pfizer settlement clarity - Investing.com
Pfizer 2026년 4월 28일 Pfizer deals extend patent life for a top-selling rare disease drug - BioPharma Dive
Pfizer 2026년 4월 24일 Biopharma bites: Avalyn eyes $200M IPO, Pfizer cuts manufacturing staff, and more from Sun Pharma, Novartis - FirstWord Pharma
Pfizer 2026년 4월 24일 Pfizer culls early PD-L1 asset after series of clinical wins, deals in cancer - BioSpace
Pfizer 2026년 4월 20일 A controversy over research monkeys highlights ambiguity over health standards - statnews.com
Pfizer 2026년 4월 20일 Exclusive | Pfizer, Amgen among 22 strategic firms eyeing Hong Kong expansion: source - South China Morning Post
Pfizer 2026년 4월 18일 Lobbying Update: $4,420,000 of PFIZER INC. lobbying was just disclosed - Quiver Quantitative